alprazolam has been researched along with Dyskinesia, Drug-Induced in 5 studies
Alprazolam: A triazolobenzodiazepine compound with antianxiety and sedative-hypnotic actions, that is efficacious in the treatment of PANIC DISORDERS, with or without AGORAPHOBIA, and in generalized ANXIETY DISORDERS. (From AMA Drug Evaluations Annual, 1994, p238)
alprazolam : A member of the class of triazolobenzodiazepines that is 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine carrying methyl, phenyl and chloro substituents at positions 1, 6 and 8 respectively. Alprazolam is only found in individuals that have taken this drug.
Dyskinesia, Drug-Induced: Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Reserpine was added for both antipsychotic coverage and reported beneficial effects in the treatment of TD." | 5.27 | Alprazolam reversal of reserpine-induced depression in patients with compensated tardive dyskinesia. ( Holt, RJ, 1984) |
| " The authors examined the possibilities of a pharmacokinetic effect of alprazolam on neuroleptic plasma levels and of a clinical effect of alprazolam." | 1.28 | Neuroleptic augmentation with alprazolam: clinical effects and pharmacokinetic correlates. ( Angrist, B; Cooper, T; Douyon, R; Peselow, E; Rotrosen, J, 1989) |
| "Reserpine was added for both antipsychotic coverage and reported beneficial effects in the treatment of TD." | 1.27 | Alprazolam reversal of reserpine-induced depression in patients with compensated tardive dyskinesia. ( Holt, RJ, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Muthusami, S | 1 |
| Basu, S | 1 |
| Kumar, A | 1 |
| Dash, A | 1 |
| Holt, RJ | 1 |
| Jordan, HW | 1 |
| Williams, BC | 1 |
| Douyon, R | 1 |
| Angrist, B | 1 |
| Peselow, E | 1 |
| Cooper, T | 1 |
| Rotrosen, J | 1 |
| Mehta, D | 1 |
| Eaton, J | 1 |
| Burch, M | 1 |
| Mehta, S | 1 |
5 other studies available for alprazolam and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Acute dyskinesia and extrapyramidal disorder in a child after ingestion of escitalopram.
Topics: Acute Disease; Alprazolam; Anti-Anxiety Agents; Anxiety; Basal Ganglia Diseases; Chest Pain; Child; | 2009 |
Alprazolam reversal of reserpine-induced depression in patients with compensated tardive dyskinesia.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Depression; Dyskinesia, Drug-Induced; Human | 1984 |
Tardive dyskinesia successfully treated with alprazolam.
Topics: Adult; Alprazolam; Dyskinesia, Drug-Induced; Female; Humans; Psychoses, Substance-Induced; Schizophr | 1990 |
Neuroleptic augmentation with alprazolam: clinical effects and pharmacokinetic correlates.
Topics: Adult; Alprazolam; Antipsychotic Agents; Basal Ganglia Diseases; Drug Synergism; Drug Therapy, Combi | 1989 |
Observations in tardive dyskinesia.
Topics: Alprazolam; Benzodiazepines; Dyskinesia, Drug-Induced; Female; Humans; Middle Aged; Mouth; Tongue | 1985 |